Skip to main content
logo
Lytix Biopharma ASA (OSL:LYTIX)
Norway flag Norway · Delayed Price · Currency is NOK
10.45
+0.15 (1.46%)
Apr 29, 2026, 11:49 AM CET

Lytix Biopharma ASA Revenue

Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
14
Market Cap
792.07M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025---
Dec 31, 202411.13M7.14M178.98%
Dec 31, 20233.99M-7.04M-63.82%
Dec 31, 202211.03M-8.28M-42.87%
Dec 31, 202119.31M15.23M373.91%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
ArcticZymes Technologies ASA118.21M
Aqua Bio Technology ASA101.51M
Arctic Bioscience AS45.90M
Oncoinvent ASA28.07M
SoftOx Solutions AS15.58M
Nykode Therapeutics AS4.57M
Thor Medical ASA839.00K
Circio Holding ASA123.00K
Revenue Rankings

Lytix Biopharma ASA News

More News